Hindustan Laboratories has filed its Draft Red Herring Prospectus (DRHP) with SEBI for an IPO, offering 1.41 million shares. The company aims to leverage fresh capital for working capital needs while providing generic medicines to government institutions.
Source :- mint – markets Read More
